Epstein Secrets

re most at risk, so that's really, really good news." FDA Broadens Investigation Of AstraZeneca's Coronavirus Vaccine Trial. Reuters (9/30, Taylor, Levine) reports the FDA "has broadened its investigation of a serious illness in" AstraZeneca's coronavirus vaccine trial to "look at data from earlier tri

remdesivir and steroids are available." Moderna Says Its Vaccine Won't Be Ready Until Spring 2021. AXi0C (9/30, Knutson, 521K) reports Moderna CEO Stephane Bancel said Wednesday that his company's coronavirus vaccine "won't be available for widespread distribution until at least spring 2021." Bancel said the

re most at risk, so that's really, really good news." FDA Broadens Investigation Of AstraZeneca's Coronavirus Vaccine Trial. Reuters (9/30, Taylor, Levine) reports the FDA "has broadened its investigation of a serious illness in" AstraZeneca's coronavirus vaccine trial to "look at data from earlier tri

remdesivir and steroids are available." Moderna Says Its Vaccine Won't Be Ready Until Spring 2021. Axios (9/30, Knutson, 521K) reports Moderna CEO Stephane Bancel said Wednesday that his company's coronavirus vaccine "won't be available for widespread distribution until at least spring 2021." Bancel said the

was the result of an effort by Senate Majority Leader McConnell "to cap a fourth wave of stimulus spending to around $1 trillion." Politico (7/27, Levine, Bresnahan, 4.29M) reports that McConnell "outlined the pillars of the proposal, which will include another round of $1,200 in direct payments, more

unced it received an additional $472 million from the U.S. government to support the development of its potential coronavirus vaccine." Moderna CEO Stephane Bancel indicated Monday that "the results from Moderna's late-stage trial could be released as soon as October." The AP (7/27, Neergaard, Hill) has more d

was the result of an effort by Senate Majority Leader McConnell "to cap a fourth wave of stimulus spending to around $1 trillion." Politico (7/27, Levine, Bresnahan, 4.29M) reports that McConnell "outlined the pillars of the proposal, which will include another round of $1,200 in direct payments, more

unced it received an additional $472 million from the U.S. government to support the development of its potential coronavirus vaccine." Moderna CEO Stephane Bancel indicated Monday that "the results from Moderna's late-stage trial could be released as soon as October." The AP (7/27, Neergaard, Hill) has more d

re most at risk, so that's really, really good news." FDA Broadens Investigation Of AstraZeneca's Coronavirus Vaccine Trial. Reuters (9/30, Taylor, Levine) reports the FDA "has broadened its investigation of a serious illness in" AstraZeneca's coronavirus vaccine trial to "look at data from earlier tri

remdesivir and steroids are available." Moderna Says Its Vaccine Won't Be Ready Until Spring 2021. Axios (9/30, Knutson, 521K) reports Moderna CEO Stephane Bancel said Wednesday that his company's coronavirus vaccine "won't be available for widespread distribution until at least spring 2021." Bancel said the